Eudaimonia Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Eudaimonia Partners’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-667	Closed	-$29K	–	689
2021 Q1	$29K	Sell	667 -246	-27%	-$11.2K	0.01%	821
2020 Q4	$37K	Buy	913 +155	+20%	+$6.05K	0.01%	687
2020 Q3	$28K	Sell	758 -180	-19%	-$6.63K	0.01%	710
2020 Q2	$32K	Buy	938 +60	+7%	+$1.86K	0.01%	601
2020 Q1	$25K	Sell	878 -894	-50%	-$29.8K	0.01%	610
2019 Q4	$62K	Buy	+1,772	New	+$59.9K	0.02%	445

Other funds holding FFTY

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Eudaimonia Partners's FFTY Position: Q2 2021 in Review

Eudaimonia Partners sold out of CapForce IBD 50 ETF (FFTY) in Q2 2021, closing a stake of 667 shares — an estimated $29K sold.

Eudaimonia Partners first reported a position in FFTY in Q4 2019 and held it in 6 quarters. The position peaked at $62K in Q4 2019. 68 funds tracked by Wall St. Rank hold FFTY as of Q2 2021.

Eudaimonia Partners reported no remaining CapForce IBD 50 ETF position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 667 CapForce IBD 50 ETF shares in Q2 2021, an estimated $29K.
Eudaimonia Partners first reported a position in CapForce IBD 50 ETF in Q4 2019 and held it in 6 quarters.
Eudaimonia Partners's CapForce IBD 50 ETF position peaked at $62K in Q4 2019.
68 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.